MedPath
FDA Product

SPIRONOLACTONE

Product approved by U.S. Food and Drug Administration (US)

Basic Information

SPIRONOLACTONE

53489-329

Regulatory Information

53489-329

ANDA089424

C73584

January 20, 2023

USA

These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960

HUMAN PRESCRIPTION DRUG LABEL

13

Company Information

146974886

Active Ingredients

ANHYDROUS LACTOSE

Code: 3SY5LH9PMK

Class Code: IACT

CARNAUBA WAX

Code: R12CBM0EIZ

Class Code: IACT

DOCUSATE SODIUM

Code: F05Q2T2JA0

Class Code: IACT

SILICON DIOXIDE

Code: ETJ7Z6XBU4

Class Code: IACT

SODIUM BENZOATE

Code: OJ245FE5EU

Class Code: IACT

HYPROMELLOSE, UNSPECIFIED

Code: 3NXW29V3WO

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

MICROCRYSTALLINE CELLULOSE

Code: OP1R32D61U

Class Code: IACT

POLYDEXTROSE

Code: VH2XOU12IE

Class Code: IACT

POVIDONE, UNSPECIFIED

Code: FZ989GH94E

Class Code: IACT

POLYETHYLENE GLYCOL, UNSPECIFIED

Code: 3WJQ0SDW1A

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

SODIUM STARCH GLYCOLATE TYPE A POTATO

Code: 5856J3G2A2

Class Code: IACT

TRIACETIN

Code: XHX3C3X673

Class Code: IACT

SPIRONOLACTONE

Quantity: 100 mg in 1 1

Code: 27O7W4T232

Class Code: ACTIB

Active Moieties

SPIRONOLACTONE

Code: 27O7W4T232

© Copyright 2025. All Rights Reserved by MedPath